Professor of Medicine, Mayo Medical School
Gastroenterology
Dr. Jorge L. Rakela, MD
|
|
Give Review
Jorge Rakela is an expert in the field of Gastroenterology. He over the years received 2 awards: "Top Doctors:Arizona State" and "Fellow (FACG)". Jorge L. Rakela, MD is a published MD. He published 68 publications, including: 'Progenitor cell markers predict outcome of patients with Hepatocellular Carcinoma beyond Milan criteria undergoing liver transplantation.' Jorge L. Rakela accepts Medicare.
Publications
- Progenitor cell markers predict outcome of patients with Hepatocellular Carcinoma beyond Milan criteria undergoing liver transplantation.
- microRNA changes in liver tissue associated with fibrosis progression in patients with Hepatitis-C.
- Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates.
- Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation.
- Complementary and Alternative Medicine: Risks and Special Considerations in Pre- and Posttransplant Patients.
- Portal Vein Thrombosis in Patients with End Stage Liver Disease Awaiting Liver Transplantation: Outcome of Anticoagulation.
- Successful rituximab therapy in refractory autoimmune Hepatitis and Evans syndrome.
- New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database.
- Evidence for liver injury in the setting of obstructive sleep apnea.
- Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.
- Six-minute walk distance predicts mortality in liver transplant candidates.
- Gene therapy and enhancement for diabetes (and other Diseases): the multiplicity of considerations.
- Short-term cardiac and noncardiac mortality following liver transplantation.
- Treatment of Hepatitis C in renal transplantation candidates: a single-center experience.
- Natural history of post-liver transplantation Hepatitis C: A review of factors that may influence its course.
- A message from the editors: Thank you.
- An unusual occurrence of giant cell Hepatitis.
- Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates.
- Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement.
- Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in Hepatitis C patients treated with combination antiviral therapy.
- Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Live...
- Persistence of Hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy.
- Living donor liver transplantation in polycystic liver Disease.
- Inpatient admissions for drug-induced liver injury: results from a single center.
- Conflict of interest policy.
- Liver transplantation in China.
- Pegylated interferon and ribavirin failures: is retreatment an option?
- Liver transplantation in the MELD era: a single-center experience.
- Successful treatment with novel triple drug combination consisting of interferon-gamma, interferon alfacon-1, and ribavirin in a nonresponder HCV patient to pegylated ...
- Living donor liver transplantation for hepatitis C-related Cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation re...
- Differential display analysis of gene expression in brains from Hepatitis C-infected patients.
- Emerging evidence of Hepatitis C virus neuroinvasion.
- Presence of Hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.
- Hepatic B-cell non-Hodgkin''s lymphoma of MALT type in the liver explant of a patient with chronic Hepatitis C infection.
- Artificial neural network and tissue genotyping of hepatocellular carcinoma in liver-transplant recipients: prediction of recurrence.
- Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
- Management of pre-liver transplantation patient--part 2.
- Management of pre-liver transplantation patients--part 1.
- Persistence of Hepatitis C virus in patients successfully treated for chronic Hepatitis C.
- Virologically compromised donor grafts in liver transplantation.
- Hepatitis C virus infection with hepatocellular carcinoma: not a controversial indication for liver transplantation.
- Primary biliary Cirrhosis and systemic amyloidosis, a new association.
- Analysis of Hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion.
- Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
- Hepatitis C virus recurrence in living donor liver transplant recipients.
- Hepatic steatosis in Hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?
- Liver transplantation for hepatocellular carcinoma: the MELD impact.
- Treatment of recurrent Hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series.
- Human immunodeficiency virus facilitates infection/replication of Hepatitis C virus in native human macrophages.
- Infection of primary human macrophages with Hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8.
- Progression of liver fibrosis in patients with chronic Hepatitis C after orthotopic liver transplantation.
- Outcome of liver transplantation for familial amyloidotic polyneuropathy.
- The use of Hepatitis C-infected grafts in liver transplantation.
- Intestinal and multivisceral transplantation: dynamics of nutritional management and functional autonomy.
- Recent advances in liver transplantation.
- Detection of Hepatitis C virus sequences in brain tissue obtained in recurrent Hepatitis C after liver transplantation.
- A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent Hepatitis C.
- Hepatitis C: magnitude of the problem.
- Detection and analysis of Hepatitis C virus sequences in cerebrospinal fluid.
- Determinants of early mortality in patients with decompensated chronic Hepatitis B treated with antiviral therapy.
- A randomized, double-blind, placebo-controlled trial of interferon-alpha and amantadine versus interferon-alpha alone in the treatment of patients with chronic hepatit...
- Cancer antigen 125 in patients with chronic liver Disease.
- Five cases of fulminant Hepatitis due to herpes simplex virus in adults.
- The origin of Hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus.
- A concise update on the status of liver transplantation for Hepatitis B virus: the challenges in 2002.
- Search for Hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication.
- Polymerase chain reaction in detecting Hepatitis C virus among blood donors.
Schools
Universidad De Santiago De Chile Facultad De Medicina
University Chile Salvador Hospital
University Of Southern California
Procedures Preformed
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Cholecystitis and Gallstones
- Cirrhosis
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- Top Doctors:Arizona State
- Fellow (FACG)
Education
-
University of Southern California - LAC+USC Medical Center -
University of Chile
Hospital
-
Mayo Clinic - Rochester, Minnesota -
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1174508691 | |
| NPPES Provider LastName | RAKELA | |
| NPPES Provider FirstName | JORGE | |
| NPPES Provider ZIPCode | 850544502 | |
| NPPES Provider State | AZ | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174508691 |
| Last Name Of The Provider | RAKELA |
| First Name Of The Provider | JORGE |
| View All |
Similar Doctors
|
Dr. Justin A. Reynolds, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael P. Simons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas J. Schwartz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph B. Fares, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fredrick I. Kenny, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert G. Gish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard P. Shaughnessy IV, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rushda Mumtaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vijayan Balan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Veronika Karasek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jodie K. Labowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Howard M. Abrams, MD
This Doctor is OpenDoctor Recommended.
|